Cynthia Pussinen
CIK: 0002163153
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ESLA
Estrella Immunopharma, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Pussinen Cynthia
Pussinen Cynthia (SEC CIK 0002163153) files insider reports with the SEC as CEO of Estrella Immunopharma, Inc. (ESLA).
Signal8 holds 1 ownership filing by Pussinen Cynthia, a Form 3, filed on Nov 3, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Pussinen Cynthia's filings is in EMERYVILLE, CA.
Other insiders filing for Estrella Immunopharma, Inc. (ESLA)
- Liu Cheng, CEO
- Xu Jiandong, Chief Financial Officer
- Jia Dengyao, Director